Helicobacter pylori (HP) colonizes the gastric mucosa and causes gastric and extra-gastric disorders. Several liver diseases, such as Non-alcoholic fatty liver disease, seem to be caused by the gastrointestinal tract, which is primarily determined by the presence of bacteria like Helicobacter pylori. The study aims to evaluate the relationship between Helicobacter pylori infection and liver diseases by measuring liver enzymes, inflammatory markers, and hematological parameters among patients with gastritis and without Helicobacter pylori infection. A total of 1,325 patients who had gastritis diagnosed by gastroscopy were included in our study. They were divided into the HP– group (340 women, 323 men) and the HP+ group (330 women, 332 men). A control group (360 women, 260 men) without gastritis or HP infection was included in this study. HP was determined using the 13C urea breath test, which requires patients to swallow a capsule with water. Measurements of liver enzymes and complete blood cell counts were done in addition to interleukin-6(IL-6) and C-reactive protein (CRP). The results showed a significant increase in IL-6 and CRP in the HP+ group. Additionally, the mean levels of leukocytes and platelets were significantly increased in the HP+ group, but liver enzymes were within the normal range in both the HP+ & HP– groups. Although Helicobacter pylori causes elevation of indices of systemic inflammation, the liver did not show evidence of fatty infiltration, as liver enzymes were within normal limits.
